PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
Rhea-AI Summary
PacBio (NASDAQ: PACB) announced that its management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 9:00 AM ET in Boston, Massachusetts. A live webcast and a replay (available for at least 30 days) will be accessible via the company’s investor website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 15 | Earnings date notice | Neutral | -2.6% | Company scheduled its second-quarter 2026 financial-results conference call. |
| May 26 | Product shipping update | Positive | +3.3% | SPRQ-Nx chemistry began worldwide shipping with lower sequencing costs. |
| May 21 | Conference participation | Neutral | -2.4% | Management announced participation in a Jefferies healthcare conference fireside chat. |
| May 19 | Strategic collaboration | Positive | +0.0% | Blank Bio announced financing and collaboration involving PacBio sequencing datasets. |
| May 11 | Clinical study results | Positive | -3.9% | HiFi sequencing study reported genomic findings in subfertility research. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
PacBio historically diverged from positive or neutral announcements in four of five comparable recent events.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 9:00 AM ET in Boston, Massachusetts.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
